Cantor Fitzgerald Remains a Buy on Regeneron (REGN)

Tip Ranks
2025.11.20 13:36
portai
I'm PortAI, I can summarize articles.

Cantor Fitzgerald analyst Carter Gould maintained a Buy rating on Regeneron with a $740 price target. Regeneron's shares closed at $702.75. The analyst has a 5.5% average return and a 51.61% success rate. Regeneron has a Moderate Buy consensus with a $742 price target, indicating a 5.59% upside. Evercore ISI also maintained a Buy rating with a $750 target.

Cantor Fitzgerald analyst Carter Gould maintained a Buy rating on Regeneron yesterday and set a price target of $740.00. The company’s shares closed yesterday at $702.75.

TipRanks Black Friday Sale

  • Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
  • Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off

Gould covers the Healthcare sector, focusing on stocks such as Eli Lilly & Co, Regeneron, and AbbVie. According to TipRanks, Gould has an average return of 5.5% and a 51.61% success rate on recommended stocks.

Regeneron has an analyst consensus of Moderate Buy, with a price target consensus of $742.00, implying a 5.59% upside from current levels. In a report released today, Evercore ISI also maintained a Buy rating on the stock with a $750.00 price target.

Source: Tip Ranks The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.